Intraoperative Noradrenaline to Control Arterial Pressure (INPRESS Study)
INPRESS
Effectiveness of Noradrenaline to Control Intraoperative Arterial Pressure in High-risk Surgical Patients: A Multicentre Prospective Randomized Controlled Trial
2 other identifiers
interventional
300
1 country
1
Brief Summary
The purpose of this study is to evaluate whether a preventive strategy of intraoperative arterial hypotension using noradrenaline can reduce the incidence of postoperative organ failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2012
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2012
CompletedFirst Posted
Study publicly available on registry
February 22, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedOctober 3, 2016
September 1, 2016
4.3 years
February 13, 2012
September 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite endpoint of postoperative SIRS and at least one major organ dysfunction
day-7
Secondary Outcomes (8)
Incidence of intraoperative hypotension
at day 7
Incidence of intraoperative hypertension
at day 7
Incidence of intraoperative bradycardia
at day 7
Intraoperative volume of fluid perfused
at day 7
Intraoperative blood losses
at day 7
- +3 more secondary outcomes
Study Arms (2)
Noradrenaline
EXPERIMENTALContinuous infusion of noradrenaline to maintain arterial blood pressure management in high-risk surgical patients
Ephedrine chorhydrate
EXPERIMENTALConventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline)using intravenous bolus of Ephedrine chorhydrate
Interventions
The primary objective of the study is to compare two strategies of intraoperative blood pressure management in high-risk surgical patients: 1- Continuous infusion of noradrenaline to maintain arterial blood pressure of no more than 10% below its baseline value; 2- Conventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline) using intravenous bolus of Ephedrine chorhydrate.
Eligibility Criteria
You may qualify if:
- Age ≥ 50 years
- ASA score ≥ 2
- Planned and unplanned surgical procedures
- Abdominal, orthopaedic and vascular surgery
- Expected duration ≥ 2 hours
- AKI risk index ≥ class 3
You may not qualify if:
- Severe preoperative hypertension (not controlled)
- Creatinine clearance \< 30 ml/min or preoperative dialysis
- Acute cardiac failure
- Preoperative sepsis
- Preoperative hemodynamic failure (shock)
- Intraoperative use of locoregional anaesthesia (epidural and spinal)
- Patient refusal
- Pregnancy and/or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Clermont-Ferrandlead
- Aguettant laboratorycollaborator
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
Related Publications (1)
Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, Bertran S, Leone M, Pastene B, Piriou V, Molliex S, Albanese J, Julia JM, Tavernier B, Imhoff E, Bazin JE, Constantin JM, Pereira B, Jaber S; INPRESS Study Group. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357. doi: 10.1001/jama.2017.14172.
PMID: 28973220DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel FUTIER
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2012
First Posted
February 22, 2012
Study Start
March 1, 2012
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
October 3, 2016
Record last verified: 2016-09